Cargando…

Clinical manifestations and treatment outcomes in prurigo pigmentosa (Nagashima disease): A systematic review of the literature

BACKGROUND: Prurigo pigmentosa (PP) is a rare inflammatory dermatosis characterized by pruritic erythematous papules that coalesce to form a reticulate pattern. PP is often misdiagnosed, and patients are treated with ineffective therapies. Although the majority of reports about PP are from East Asia...

Descripción completa

Detalles Bibliográficos
Autores principales: Mufti, Asfandyar, Mirali, Sara, Abduelmula, Abrahim, McDonald, Katherine Ann, Alabdulrazzaq, Shaikhah, Sachdeva, Muskaan, Yeung, Jensen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8362297/
https://www.ncbi.nlm.nih.gov/pubmed/34409375
http://dx.doi.org/10.1016/j.jdin.2021.03.003
_version_ 1783738133948399616
author Mufti, Asfandyar
Mirali, Sara
Abduelmula, Abrahim
McDonald, Katherine Ann
Alabdulrazzaq, Shaikhah
Sachdeva, Muskaan
Yeung, Jensen
author_facet Mufti, Asfandyar
Mirali, Sara
Abduelmula, Abrahim
McDonald, Katherine Ann
Alabdulrazzaq, Shaikhah
Sachdeva, Muskaan
Yeung, Jensen
author_sort Mufti, Asfandyar
collection PubMed
description BACKGROUND: Prurigo pigmentosa (PP) is a rare inflammatory dermatosis characterized by pruritic erythematous papules that coalesce to form a reticulate pattern. PP is often misdiagnosed, and patients are treated with ineffective therapies. Although the majority of reports about PP are from East Asia, patients of all backgrounds can be affected. OBJECTIVES: To perform a systematic review of reported PP cases with the purpose of summarizing the clinical presentation and treatment of PP. METHODS: MEDLINE and Embase were searched for original articles describing PP. We identified 115 studies from 24 countries representing 369 patients to include in the analysis. RESULTS: Of the 369 patients included in the analysis, the mean age was 25.6 years (range: 13-72 years) with 72.1% (266 of 369) female. Risk factors or aggravating factors were described in 52.3% (193 of 369) of patients and included dietary changes (25.5%, 94 of 369), friction (8.4%, 31 of 369), sweat (7.6%, 28 of 369), and ketonuria (5.1%, 19 of 369). Of those patients who experienced PP following dietary changes, 40.4% (38 of 94) started a ketogenic diet. Minocycline monotherapy was the most frequently prescribed treatment for PP (20.9%, 77 of 369), achieving complete resolution in 48.1% (37 of 77) of patients. CONCLUSIONS: PP is sometimes associated with ketogenic diets and can be effectively managed with oral tetracyclines.
format Online
Article
Text
id pubmed-8362297
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-83622972021-08-17 Clinical manifestations and treatment outcomes in prurigo pigmentosa (Nagashima disease): A systematic review of the literature Mufti, Asfandyar Mirali, Sara Abduelmula, Abrahim McDonald, Katherine Ann Alabdulrazzaq, Shaikhah Sachdeva, Muskaan Yeung, Jensen JAAD Int Systematic Reviews/Meta-Analyses BACKGROUND: Prurigo pigmentosa (PP) is a rare inflammatory dermatosis characterized by pruritic erythematous papules that coalesce to form a reticulate pattern. PP is often misdiagnosed, and patients are treated with ineffective therapies. Although the majority of reports about PP are from East Asia, patients of all backgrounds can be affected. OBJECTIVES: To perform a systematic review of reported PP cases with the purpose of summarizing the clinical presentation and treatment of PP. METHODS: MEDLINE and Embase were searched for original articles describing PP. We identified 115 studies from 24 countries representing 369 patients to include in the analysis. RESULTS: Of the 369 patients included in the analysis, the mean age was 25.6 years (range: 13-72 years) with 72.1% (266 of 369) female. Risk factors or aggravating factors were described in 52.3% (193 of 369) of patients and included dietary changes (25.5%, 94 of 369), friction (8.4%, 31 of 369), sweat (7.6%, 28 of 369), and ketonuria (5.1%, 19 of 369). Of those patients who experienced PP following dietary changes, 40.4% (38 of 94) started a ketogenic diet. Minocycline monotherapy was the most frequently prescribed treatment for PP (20.9%, 77 of 369), achieving complete resolution in 48.1% (37 of 77) of patients. CONCLUSIONS: PP is sometimes associated with ketogenic diets and can be effectively managed with oral tetracyclines. Elsevier 2021-04-10 /pmc/articles/PMC8362297/ /pubmed/34409375 http://dx.doi.org/10.1016/j.jdin.2021.03.003 Text en © 2021 by the American Academy of Dermatology, Inc. Published by Elsevier Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Systematic Reviews/Meta-Analyses
Mufti, Asfandyar
Mirali, Sara
Abduelmula, Abrahim
McDonald, Katherine Ann
Alabdulrazzaq, Shaikhah
Sachdeva, Muskaan
Yeung, Jensen
Clinical manifestations and treatment outcomes in prurigo pigmentosa (Nagashima disease): A systematic review of the literature
title Clinical manifestations and treatment outcomes in prurigo pigmentosa (Nagashima disease): A systematic review of the literature
title_full Clinical manifestations and treatment outcomes in prurigo pigmentosa (Nagashima disease): A systematic review of the literature
title_fullStr Clinical manifestations and treatment outcomes in prurigo pigmentosa (Nagashima disease): A systematic review of the literature
title_full_unstemmed Clinical manifestations and treatment outcomes in prurigo pigmentosa (Nagashima disease): A systematic review of the literature
title_short Clinical manifestations and treatment outcomes in prurigo pigmentosa (Nagashima disease): A systematic review of the literature
title_sort clinical manifestations and treatment outcomes in prurigo pigmentosa (nagashima disease): a systematic review of the literature
topic Systematic Reviews/Meta-Analyses
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8362297/
https://www.ncbi.nlm.nih.gov/pubmed/34409375
http://dx.doi.org/10.1016/j.jdin.2021.03.003
work_keys_str_mv AT muftiasfandyar clinicalmanifestationsandtreatmentoutcomesinprurigopigmentosanagashimadiseaseasystematicreviewoftheliterature
AT miralisara clinicalmanifestationsandtreatmentoutcomesinprurigopigmentosanagashimadiseaseasystematicreviewoftheliterature
AT abduelmulaabrahim clinicalmanifestationsandtreatmentoutcomesinprurigopigmentosanagashimadiseaseasystematicreviewoftheliterature
AT mcdonaldkatherineann clinicalmanifestationsandtreatmentoutcomesinprurigopigmentosanagashimadiseaseasystematicreviewoftheliterature
AT alabdulrazzaqshaikhah clinicalmanifestationsandtreatmentoutcomesinprurigopigmentosanagashimadiseaseasystematicreviewoftheliterature
AT sachdevamuskaan clinicalmanifestationsandtreatmentoutcomesinprurigopigmentosanagashimadiseaseasystematicreviewoftheliterature
AT yeungjensen clinicalmanifestationsandtreatmentoutcomesinprurigopigmentosanagashimadiseaseasystematicreviewoftheliterature